Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6190)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11087)
  2. Hematologic Malignancies, Division of (10638)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3721)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (308)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13544)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frontal cortex pyramidal neuron expression profiles differentiate the prodromal stage from progressive degeneration across the Alzheimer's disease spectrum
    Journal Article

    Labuza, A.; Alldred, M. J.; Pidikiti, H.; Malek-Ahmadi, M. H.; Lee, S. H.; Heguy, A.; Coleman, P. D.; Chakrabarty, S.; Chiosis, G.; Mufson, E. J.; more...
    Alzheimer's and Dementia (2025)

    Fulltext@MSK | Save
  • Intracellular metabolic gradients dictate dependence on exogenous pyruvate
    Journal Article

    Jackson, B. T.; Montero, A. M.; Chakraborty, S.; Brunner, J. S.; Arnold, P. K.; Bridgeman, A. E.; Todorova, P. K.; Paras, K. I.; Finley, L. W. S.
    Nature Metabolism (2025)

    Fulltext@MSK | Save
  • Pneumocystis jirovecii pneumonia with use of brentuximab vedotin in treatment-naïve Hodgkin lymphoma
    Correspondence

    Gurumurthi, A.; Henshaw, L.; Falchi, L.; Moskowitz, A.; Noy, A.; Seo, S.; Stuver, R.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome
    Guidelines

    Goyal, A.; O'Leary, D.; Dabaja, B.; Weng, W. K.; Zain, J.; Cutler, C.; Guitart, J.; Kim, Y. H.; Geskin, L. J.; Hoppe, R. T.; more...
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save
  • Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): Results from the Pediatric Proton/Photon Consortium Registry (PPCR)
    Journal Article

    Krisch, J. M.; Ermoian, R. P.; Indelicato, D. J.; Lee, J. Y.; Perentesis, J. P.; Perkins, S. M.; Laack, N. N. 2nd; Chang, J. H.; MacEwan, I. J.; Wolden, S. L.; more...
    Journal of Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • Long-term (≥5-year) remission and survival after treatment with ciltacabtagene autoleucel in CARTITUDE-1 patients with relapsed/refractory multiple myeloma
    Journal Article

    Jagannath, S.; Martin, T. G.; Lin, Y.; Cohen, A. D.; Raje, N.; Htut, M.; Deol, A.; Agha, M.; Berdeja, J. G.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns and real-world outcomes of molecular subgroups in patients with AML receiving frontline venetoclax-based therapy
    Journal Article

    Lachowiez, C. A.; Barcellos, A.; Zettler, C. M.; Belli, A. J.; Fernandes, L. L.; Hansen, E.; Wang, C. K.; Owusu, H. F.; Zeidan, A. M.; Stein, E. M.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Characterization of belantamab mafodotin-induced corneal changes in patients with multiple myeloma
    Journal Article

    Lee, V.; Hultcrantz, M.; Petrone, S.; Lewis, E. W.; Banna, H.; Lichtman, E.; Thulasi, P.; Quick, A. A.; Jeng, B. H.; Sunshine, S. B.; more...
    JAMA Ophthalmology (2025)

    Fulltext@MSK | Save
  • High-dose-rate brachytherapy for vaginal rhabdomyosarcoma (RMS): Lessons learned at a single institution
    Journal Article

    Lapen, K.; Tringale, K. R.; Wexler, L. H.; Friedman, D. N.; Cohen, G. N.; LaQuaglia, M. P.; Wolden, S.
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save